UNITED STATES of America, Appellee, v. William SCULLY, aka Liam Scully Defendant-Appellant, Shahrad Rodi Lameh, Defendant.
Docket No. 16-3073-cr
United States Court of Appeals, Second Circuit.
December 13, 2017
Argued: August 24, 2017
Bottom line: Reading the record in the light most favorable to the judge‘s ruling, and keeping in mind that his decision must stand if any reasonable view of the evidence supports it, I believe the unreversed findings and the uncontested evidence establish—under controlling precedent—that Aiken was an “overnight guest” of Bonnett in a constitutional sense. Which again means Aiken had a legitimate expectation of privacy in the motel room and so could challenge the search. And because the majority (though conscientious) sees the matter differently, I respectfully (but unequivocally) dissent.
SCOTT A. RESNIK (Michael M. Rosensaft, on the brief), Katten Muchin Rosenman LLP, New York, NY, for Defendant-Appellant.
Before: POOLER and LYNCH, Circuit Judges, and COGAN, District Judge.*
* Judge Brian M. Cogan, of the United States District Court for the Eastern District of New York, sitting by designation.
GERARD E. LYNCH, Circuit Judge:
William Scully appeals from a judgment of conviction entered following a five-week jury trial in the United States District Court for the Eastern District of New York (Arthur D. Spatt, Judge).
The jury found Scully guilty of mail and wire fraud and conspiracy to commit the same in violation of
The main issue on appeal is whether the district court properly excluded evidence relating to Scully‘s advice-of-counsel defense. Because we find that the evidence was admissible and its exclusion was not harmless error, we VACATE the district court‘s judgment and REMAND for further proceedings consistent with this decision.1
BACKGROUND
The jury found Scully guilty of all charges relevant to this appeal, so we consider the evidence in the light most favor-
I. The Rise and Fall of Pharmalogical
Scully and Shahrad Rodi Lameh founded Pharmalogical, Inc., in 2002 or 2003 as equal owners, Scully running the company‘s day-to-day operations and Lameh managing payments and providing most of the capital. They initially planned to acquire pharmaceutical products from manufacturers and sell those products to retail customers (such as doctors, hospitals, and clinics) as a wholesale distributor. To that end, Pharmalogical received a license from New York State authorizing it to act as a wholesale distributor of pharmaceutical products. Pharmalogical struggled to turn a profit for several years, and eventually Scully decided to set the company on a new course: parallel importing. That is, rather than buying prescription drugs and medical devices approved by the U.S. Food and Drug Administration from the drug manufacturers, the company would import foreign versions of FDA-approved products into the United States from European distributors. Pharmalogical could purchase these drugs at reduced prices and then sell them to customers in the United States for far less than the going rate on the domestic market. Around the same time, the company also began doing business under the name Medical Device King or MDK.
Pharmalogical launched its parallel importing business around 2009 with purchases of Botox from a Canadian distributor. One of the company‘s first potential customers, Dr. James Avellini, expressed concern that the product labels did not include a National Drug Code (“NDC“)2 and requested assurances of the product‘s legitimacy before he placed an order. Dr. Avellini‘s inquiry prompted Scully and Lameh to approach an attorney, Richard Gertler, then of Thaler & Gertler, LLP, to research whether it was legal to resell the imported products in the United States. Gertler produced an opinion letter dated May 27, 2009, indicating that “Pharmalogical has not received any correspondence or notification from the FDA advising that Pharmalogical is operating in violation of any of the provisions of the Federal Food, Drug and Cosmetic Act,” and that “Pharmalogical has no reason to believe that it is not in full compliance with the FFDCA or any other statute or regulation.” App‘x 400. The letter satisfied Dr. Avellini and others that Pharmalogical was authorized to sell Botox.
Scully and Lameh soon learned that the Canadian distributor with which they had been placing Botox orders simply forwarded those orders to a European distributor, which then shipped the product to Pharmalogical in the United States. Pharmalogical decided to cut out the Canadian middleman and began to place orders for Botox and a second product, Mirena intrauterine devices, directly with the European company. They also began buying Mirena IUDs at an even lower price from a Turkish company that sold the devices with Finnish- and Turkish-language labels and packaging. Around that time, the FDA responded to an inquiry from Scully regarding the sale of the Mirena IUDs, notifying him that foreign-made versions of FDA-approved drugs were considered unapproved new drugs. Scully and Lameh asked Gertler to look into the matter and Gertler once again produced an opinion
As had occurred with Botox, when a potential customer for the Mirena IUDs, Planned Parenthood, requested assurances that the product was lawful to purchase, Scully and Lameh provided Gertler‘s Mirena letter. Planned Parenthood then placed a small order for Mirena IUDs, but then rejected and returned the order because the product labels were missing NDCs. Scully and Lameh nevertheless resolved to continue selling the Mirena IUDs to doctors. As the company‘s sales of Botox and Mirena IUDs increased, Scully and Lameh further expanded their business into oncology products. Gertler did not issue a separate legal opinion regarding Pharmalogical‘s importation and sale of oncology drugs.
The first signs of trouble for Pharmalogical came in May 2012, when FDA agents executed warrants to search Pharmalogical‘s offices. In response, Gertler and other lawyers, including Peter Tomao for Scully and Geoffrey Kaiser for Lameh, arranged meetings with prosecutors, and Pharmalogical ceased selling oncology products. But Scully made at least one shipment of oncology products after the search through Taranis Medical Corp., a company that he had incorporated in December 2011 and for which he executed written agreements authorizing it to use Pharmalogical‘s wholesale license to distribute prescription drugs, all without Lameh‘s knowledge. Scully did not consult Gertler or Lameh before making the Taranis shipment.
II. Indictment and Pre-Trial Motions
Scully and Lameh were indicted and arrested in April 2014. The indictment alleged that the two men used Pharmalogical (doing business as Medical Device King and MDK) and Taranis, to knowingly and willfully import foreign versions of prescription drugs and medical devices not approved by the FDA for use in the United States, and that they sold those products to customers under materially false and fraudulent pretenses. After initially pleading not guilty, Lameh entered into a cooperation agreement with the government and pled guilty to conspiracy to commit wire fraud and conspiracy to distribute misbranded drugs.
Prior to trial, Scully moved to strike all counts based on violations of FDA regulations, as well as Count 72, charging fraudulent importation and transportation of goods, and Count 73, charging trafficking in counterfeit drugs. The district court denied the motions, but ordered the government to provide a bill of particulars identifying the specific fraud alleged in each count and the misbranding alleged in each count. The government provided such a bill, and obtained a superseding 75-count indictment that added two new counts charging Scully with the introduction of unapproved new drugs into interstate commerce and the unlicensed wholesale distribution of prescription drugs.
III. The Trial
At trial, the government called dozens of witnesses to prove that Scully purchased prescription drugs and medical devices with labels bearing instructions in foreign languages and lacking NDCs from foreign distributors, misrepresented those products to medical professionals as FDA-approved products with English-language labeling, and continued selling such pharmaceuticals through Taranis after government officials raided Pharmalogical. The witnesses included Lameh, who detailed Pharmalogical‘s activities and Scully‘s knowledge regarding the legality of the
At the close of the government‘s case, Scully moved to dismiss all counts of the superseding indictment for insufficient evidence. The district court denied that motion except as to Counts 72 and 73, which charged fraudulent importation and transportation of goods and trafficking in counterfeit drugs, on which the court reserved decision.
Scully then advanced an advice-of-counsel defense, contending that he lacked the requisite intent for all counts alleging fraud due to his good faith reliance on advice from Gertler and Tomao regarding the legality of his conduct. The defense called Gertler as its first witness, and both parties questioned him extensively on the nature of his relationship with Scully. In particular, Gertler testified to his legal experience with health care matters, the information that Scully shared with him about Pharmalogical‘s business and products, the advice he provided to Scully and Pharmalogical, and Tomao‘s role on Scully‘s legal team.
The government‘s direct examination of Lameh and cross-examination of Gertler and Scully effectively undermined Scully‘s advice-of-counsel defense as to Gertler. In particular, the government presented evidence that Scully and Lameh only approached Gertler for opinion letters after they had purchased products and potential customers raised concerns about the legitimacy of the products sold by Pharmalogical; that Scully provided Gertler with false information, including that the products sold by Pharmalogical were FDA-approved and that Pharmalogical followed all laws and regulations for importing their products into the United States; that Scully did not inform Gertler that Pharmalogical would advertise FDA-approved products on its website, but sometimes provide to customers foreign equivalents of those products that were not FDA-approved; and that Scully did not inform Gertler that U.S. customs officials seized, sometimes permanently, some of the prescription drugs Pharmalogical purchased from abroad because they were misbranded.
The defense did not call Tomao to testify. Instead, they sought to introduce evidence of Tomao‘s legal advice to Scully through Scully‘s own testimony. The government objected to that course of action after the following exchange during defense counsel‘s direct examination of Scully:
Q. Did Mr. Tomao also give you an oral legal opinion as to his conclusions about your business model?
A. Yes. We sat down and met at Mr. Gertler‘s office. We had a meeting. It was Rodi, myself, Mr. Gertler and Peter Tomao, and Peter had given his approval and said the business was completely legal.
App‘x 279. The government moved to strike, which the district court sustained as to “[t]he statement that Peter gave us his approval.” Id. As the court explained:
When we have the alternative of his state of mind and the jury hearing hearsay, very important testimony, the answer is no. I will not permit that. ... Bring in Mr. Tomao. ... It is extremely prejudicial to the Government for you to allow [Scully] to give that testimony. That overtakes the state of mind in my opinion. ...
It is not an exception to this hearsay rule which is that where you have a major figure, a very important figure which you do not bring in, I‘m not going to let the hearsay come in, state of mind or otherwise.
Id. at 280-81.
The following day, Scully asked the district court to reconsider that ruling, noting that the defense offered evidence of Tomao‘s advice to Scully not for the truth of the matters asserted, but to establish Scully‘s state of mind as part of the advice-of-counsel defense. Accordingly, the defense argued, that evidence fell outside of the hearsay rule. See
This testimony is extremely important to the defense, and as the prosecutor said, totally prejudicial to the government. Where is Mr. Peter Tomao? We all know he is a trial lawyer readily available. Why should I permit this totally prejudicial evidence for a state of mind where it is outweighed by the danger of unfair prejudice? ... So I rule that the evidence‘s probative value is substantially outweighed by the danger of unfair prejudice.
App‘x 302. The court then again pointed out that Tomao was “readily available” and “in court every day.” Id.
After both sides rested their cases, the district court dismissed Counts 72 and 73 for lack of sufficient evidence, as well as Counts 6 and 22, charging mail and wire fraud relating to a Dr. R. Daniel Jacob, on the government‘s motion because Dr. Jacob was unable to testify at trial. Although the court did not provide printed copies of its proposed charge to the parties, it read to them its proposed jury charge, including its instructions on the advice-of-counsel defense. The defense‘s only requested changes to the court‘s instructions on the advice-of-counsel defense were to remove the term “affirmative” from descriptions of the defense and to change references to Scully‘s “crimes” to his “acts.” App‘x 333-34. The government raised no objections to those proposed changes, and the court accepted them both.
Later that day, however, the government filed a letter motion objecting on various grounds to the court‘s proposed charge and verdict sheet on the advice-of-counsel defense. Scully‘s counsel responded by letter arguing that “[t]here is no reason or basis for the Court to now rewrite the advice-of-counsel instruction it drafted and discussed to the satisfaction o[f] both parties” and urging the court to use the charge “as agreed during the Court‘s charging conference.” G. App‘x 56. The court denied the government‘s motion as to the jury charge, and proceeded to instruct the jury on the 71 remaining counts in the superseding indictment. Of relevance to this appeal, the court instructed the jury on Scully‘s advice-of-counsel defense as follows:
Now I am going to instruct you on the defense of reliance on the advice of an attorney. ... In this regard, I instruct you that the defendant has the burden of producing evidence to support the defense, but the burden of proof in this case remains on the government. I further instruct you that the defendant has to satisfy the following three elements to sustain the defense of advice of counsel: First, that the defendant sought the advice of counsel honestly and in good faith prior to committing any of these crimes;
Second, that the defendant fully and honestly placed all of the facts before his counsel, and; Third, that the defendant followed his counsel‘s advice in good faith and honestly believing it to be correct and intending that his actions are lawful. Each of these three requirements must be satisfied.
App‘x 368-69.
The court also described to the jury how it was to consider the advice-of-counsel defense on the verdict form:
As to each count you will be asked to render your verdict and mark the verdict sheet. The verdict sheet will list every count. And next to it ... the words “not guilty or guilty.” ... [I]f you find the defendant guilty of that count, then you will be asked to determine if the defense of “advice of counsel” has been established. Next to the question on advice of counsel there will be two markings, “established,” if the defense has been established and “not established” if the defense has not been established. If you find the defendant guilty of the crime at issue, but also find that the defense of advice of counsel has been established, I advise you that the defendant will be acquitted of that count.
App‘x 369-70.
The jury deliberated for two days and returned a guilty verdict on all counts except five counts of wire fraud.
IV. Post-Trial Developments
After the jury‘s verdict, Scully moved for a judgment of acquittal on all counts and, in the alternative, a new trial. The district court granted the motion only as to Counts 45 and 62, which concerned the purchase and sale of Altuzan to the Hematology and Oncology Center of Iowa. The court then entered judgment and sentenced Scully to 60 months in prison.3 This appeal followed.
DISCUSSION
On appeal, Scully does not renew his post-trial challenge to all counts for lack of sufficient evidence to prove criminal intent.4 Instead, Scully‘s main challenge on appeal focuses on two alleged impediments to the fair presentation and consideration of his advice-of-counsel defense, his only defense at trial: the district court‘s exclusion of evidence of Tomao‘s legal advice and the jury instructions on the advice-of-counsel defense. We now turn to those issues.
I. Evidence of Tomao‘s Legal Advice
Scully argues that the district court abused its discretion when it excluded testimony and evidence relating to the legal advice that Scully received from Tomao. The abuse of discretion standard is “famously slippery” and “there has been little consensus over the years as to precisely what the phrase means.” Zervos v. Verizon New York, Inc., 252 F.3d 163, 168 n.4 (2d Cir. 2001) (Cabranes, J.). A district court‘s evidentiary determinations generally “will not be disturbed unless they are manifestly erroneous.” Davis v. Velez, 797 F.3d 192, 201 (2d Cir. 2015) (internal quotation marks omitted). “Under
During Scully‘s trial, the district court ruled that Scully could not introduce evidence of Tomao‘s legal advice through Scully‘s direct examination. The court initially excluded that evidence on hearsay grounds, basing that decision on its sense that the importance of Tomao‘s advice and the “extremely prejudicial” nature of that testimony to the government‘s case “overt[ook] the state of mind” exception to the hearsay rule. App‘x 281.
Even after defense counsel demonstrated that the testimony was not hearsay because it went to Scully‘s state of mind and was not offered for the truth of the matter asserted, the court continued to maintain that the evidence was unfairly prejudicial to the government and therefore inadmissible under
We find that the district court erred in its balancing of the probative value and prejudicial effect of the proposed evidence under
Nor was it appropriate to require that Scully call Tomao as a witness in order to ensure the reliability of Scully‘s testimony. There may be reasons to doubt the credibility and reliability of Scully‘s testimony in that regard, and the government may well be correct that the docu-
It was thus error for the district court, in effect, to consider as an element of prejudice to the government the increased possibility that Scully‘s testimony about Tomao‘s oral advice would be false if uncorroborated by testimony from Tomao himself. One party to a trial will frequently believe that testimony offered by the other side is false or misleading. That, however, is not a factor to be weighed against the receipt of otherwise admissible testimony. The opposing party has ample means to challenge the credibility of a party‘s testimony, which is to be decided by the jury. Here, for example, if Scully had been permitted to testify to what he claims Tomao told him, the government could have cross-examined him about that testimony, noted in summation the self-serving nature of the testimony due to Scully‘s interest in the outcome and the conspicuous lack of corroboration from Tomao himself, challenged the likelihood that a reputable attorney would have given such a significant opinion orally, or called Tomao as a rebuttal witness, as it did Lameh‘s attorney Geoffrey Kaiser. The government‘s strategic preference not to take those steps does not affect the admissibility of Scully‘s evidence.
The government‘s argument that evidence of Tomao‘s advice to Scully would have been cumulative is also unavailing. Scully‘s entire defense rested on the advice he allegedly received from two lawyers, Gertler and Tomao. The government effectively cross-examined Gertler, raising questions as to Scully‘s version of the relevant events and Gertler‘s level of experience with FDA matters. Evidence of the legal advice of another attorney, and in particular a former federal prosecutor with acknowledged experience working on FDA compliance matters, might well have bolstered Scully‘s case in the eyes of the jury. Though the record includes references to Tomao and his role on Scully‘s legal team, such stray bits of testimony do not substitute for Scully‘s direct account of the advice that he claims to have received from Tomao, particularly where the case revolved around what Scully told his attorneys and what they told him.
Finally, we conclude that that error was not harmless. In assessing whether the improper exclusion of defense evidence was harmless, we consider (1) the importance of the unrebutted assertions to the government‘s case; (2) whether the excluded material was cumulative; (3) the presence or absence of evidence corroborating or contradicting the government‘s case on the factual questions at issue; (4) the extent to which the defendant was otherwise permitted to advance the defense; and (5) the overall strength of the prosecution‘s case.
On that basis, Scully is entitled to a new trial.
II. Advice-of-Counsel Jury Instructions
Scully also argues that the district court‘s jury charge on the advice-of-counsel defense improperly placed the burden on Scully to establish the defense, rather than on the government to demonstrate that Scully had the requisite intent. Scully waived that argument, however, when defense counsel, in response to the government‘s letter motion objecting to the advice-of-counsel jury charge and verdict sheet, urged that “[t]here is no reason or basis for the Court to now rewrite the advice-of-counsel instruction it drafted and discussed to the satisfaction o[f] both parties” and that the charge “should be read to the jury as agreed during the Court‘s charging conference.” G. App‘x 56. Such affirmative endorsement of the district court‘s jury instructions waives the right to appellate review. See United States v. Hertular, 562 F.3d 433, 444 (2d Cir. 2009); cf. United States v. Crowley, 318 F.3d 401, 414 (2d Cir. 2003). Accordingly, were we not remanding for a new trial in any event, Scully‘s belated appellate objection to the district court‘s jury instructions would not warrant vacating his conviction. But because a new trial is required on other grounds, we take the opportunity to provide some guidance to the district court on the issue.
While “the prosecution must prove guilt beyond a reasonable doubt,” “the long-accepted rule was that it was constitutionally permissible to provide that various affirmative defenses were to be proved by the defendant.” Patterson v. New York, 432 U.S. 197, 211, 97 S.Ct. 2319, 53 L.Ed.2d 281 (1977). An affirmative defense is “[a] defendant‘s assertion of facts and arguments that, if true, will defeat the plaintiff‘s or prosecution‘s claim, even if all the allegations in the complaint are true.” Black‘s Law Dictionary 451 (8th ed. 2004); see also Saks v. Franklin Covey Co., 316 F.3d 337, 350 (2d Cir. 2003). In a fraud case, however, the advice-of-counsel defense is not an affirmative defense that defeats liability even if the jury accepts the government‘s allegations as true. Rather, the claimed advice of counsel is evidence that, if believed, can raise a reasonable doubt in the minds of the jurors about whether the government has proved the required element of the offense that the defendant had an “unlawful intent.” United States v. Beech-Nut Nutrition Corp., 871 F.2d 1181, 1194 (2d Cir. 1989). The government must carry its burden to prove Scully‘s intent to defraud, and that burden does not diminish because Scully raised an advice-of-counsel defense. Accordingly, the district court must advise the jury in unambiguous terms that the government at all times bears the burden of proving beyond a reasonable doubt that the defendant had the state of mind required for conviction on a given charge.
That said, defendants are entitled to an advice-of-counsel instruction only if there are sufficient facts in the record to support the defense. United States v. Evangelista, 122 F.3d 112, 117 (2d Cir. 1997). There must be evidence such that a reasonable juror could find that the defendant “honestly and in good faith sought the advice of counsel,” “fully and honestly laid all the facts before his counsel,” and “in good faith and honestly followed counsel‘s advice.” United States v. Colasuonno, 697 F.3d 164, 181 (2d Cir. 2012) (brackets and internal quotation marks omitted). Once the evidence meets
In drafting a more appropriate instruction on the advice-of-counsel defense, it may be tempting to turn to the Supreme Court‘s century-old formulation, adopted by this Court in Beech-Nut:
[I]f a man honestly and in good faith seeks advice of a lawyer as to what he may lawfully do ..., and fully and honestly lays all the facts before his counsel, and in good faith and honestly follows such advice, relying upon it and believing it to be correct, and only intends that his acts shall be lawful, he could not be convicted of [a] crime which involves willful and unlawful intent[,] even if such advice were an inaccurate construction of the law. But, on the other hand, no man can willfully and knowingly violate the law and excuse himself from the consequences thereof by pleading that he followed the advice of counsel.
871 F.2d at 1194-95 (alterations in original), quoting Williamson v. United States, 207 U.S. 425, 453, 28 S.Ct. 163, 52 L.Ed. 278 (1908). But that language, like many excerpts from appellate opinions articulating legal principles for an audience of judges and lawyers, is unwieldy for a jury instruction.
More manageable contemporary formulations are available. The treatise on jury instructions authored by the late Leonard B. Sand, a wise and experienced trial judge, and his colleagues, offers the following template that translates the Williamson/Beech-Nut formulation into clearer language:
You have heard evidence that the defendant received advice from a lawyer and you may consider that evidence in deciding whether the defendant acted willfully and with knowledge.
The mere fact that the defendant may have received legal advice does not, in itself, necessarily constitute a complete defense. Instead, you must ask yourselves whether the defendant honestly and in good faith sought the advice of a competent lawyer as to what he may lawfully do; whether he fully and honestly laid all the facts before his lawyer; and whether in good faith he honestly followed such advice, relying on it and believing it to be correct. In short you should consider whether, in seeking and obtaining advice from a lawyer, the de-fendant intended that his acts shall be lawful. If he did so, it is the law that a defendant cannot be convicted of a crime that involves willful and unlawful intent, even if such advice were an inaccurate construction of the law.
On the other hand, no man can willfully and knowingly violate the law and excuse himself from the consequences of his conduct by pleading that he followed the advice of his lawyer.
Whether the defendant acted in good faith for the purpose of seeking guidance
as to the specific acts in this case, and whether he made a full and complete report to his lawyer, and whether he acted substantially in accordance with the advice received, are questions for you to determine.
1 Leonard B. Sand, et al., Modern Federal Jury Instructions: Criminal, Instruction 8-4, at 8-19 (2017).
We also refer district courts to the model instructions drafted by our sister circuits, particularly the Seventh Circuit‘s model, which reads as follows:
If the defendant relied in good faith on the advice of an attorney that his conduct was lawful, then he lacked the [intent to defraud; willfulness; etc.] required to prove the offense[s] of [identify the offense] charged in Count[s] ---.
The defendant relied in good faith on the advice of counsel if:
1. Before taking action, he in good faith sought the advice of an attorney whom he considered competent to advise him on the matter; and
2. He consulted this attorney for the purpose of securing advice on the lawfulness of his possible future conduct; and
3. He made a full and accurate report to his attorney of all material facts that he knew; and
4. He then acted strictly in accordance with the advice of this attorney.
[You may consider the reasonableness of the advice provided by the attorney when determining whether the defendant acted in good faith.]
The defendant does not have to prove his good faith. Rather, the government must prove beyond a reasonable doubt that the defendant acted [with intent to defraud; willfully; etc.] as charged in Count[s] ---.
Seventh Circuit Pattern Criminal Jury Instructions, § 6.12 (2012 ed.).
Neither of these instructions muddles the question of burden of proof by injecting the concept of a “burden of production”5 or asserting that a defendant must “show” or “establish” or “satisfy” the jury about particular facts. The last paragraph of the Seventh Circuit instruction, which explicitly informs the jury that a defendant need not establish her good faith, seems to us a valuable final reminder of the burden of proof that the prosecution must carry and should be included in any instruction to the jury on the advice-of-counsel defense.6
III. Scully‘s Challenges to Additional Counts
In addition to the claims of trial error discussed above, Scully also contests his guilt on several specific counts of which he was convicted. First, Scully argues that the district court should have dismissed all counts premised on his distribution of prescription drugs not bearing English-language labeling because those requirements are imposed by FDA regulation and therefore cannot serve as the basis of a criminal charge. Second, Scully claims that there was insufficient evidence to convict him of the two remaining counts relating to Dr. Jacob because Dr. Jacob did not testify at trial. We find no merit to these arguments.
Scully also argues that the record lacked sufficient evidence to support his conviction on Counts 40 and 57, charging introduction of Botox into interstate commerce and receipt of Botox in interstate commerce and delivery thereof to Dr. R. Daniel Jacob for pay with the intent to defraud or mislead. Because Dr. Jacob was unable to testify at trial due to illness, Scully argues that the government failed to prove that Dr. Jacob relied on Scully‘s representations when purchasing the misbranded Botox, thereby defeating any finding of fraudulent intent. But reliance by a victim is not an element of felony introduction of misbranded drugs into interstate commerce nor of felony receipt of misbranded drugs in interstate commerce and delivery thereof for pay, which are complete when the defendant formulates a fraudulent scheme and introduces or receives and sells misbranded drugs through interstate commerce. Moreover, “direct proof of defendant‘s fraudulent intent is not necessary.” United States v. Guadagna, 183 F.3d 122, 129 (2d Cir. 1999). “[A] jury may bring to its analysis of intent on individual counts all the circumstantial evidence it has received on the scheme and the purpose of the scheme in which the defendant allegedly participated.” Id. at 130. There is substantial evidence in the record from which a jury could find that Scully was engaged in a scheme to defraud doctors, clinics, and hospitals; the whole corporate enterprise was built on Scully‘s assurances that the drugs sold in the name of Pharmalogical, Medical Device King, and Taranis were appropriate for sale in the United States. The government need not present testimony from each victim of Scully‘s fraudulent scheme to prove intent as to that victim.
CONCLUSION
For the reasons stated above, the judgment of the district court is VACATED and REMANDED for further proceedings in accordance with this opinion.